News Roundup: January 16 to January 20
Your weekly roundup of the latest news from Drug Topics®.
Urgent Need to Increase Vaccinations in Children
Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.
Positive Topline Results Announced from Pivotal Efficacy Trial of mRNA Vaccine for RSV
Moderna has announced positive topline results from a phase 3 pivotal efficacy study of mRNA-1345, the company’s investigational mRNA vaccine targeting respiratory syncytial virus (RSV) in older adults.
Recommended Immunization Schedules for 2023
The updates include new recommendations for COVID-19 and pneumococcal vaccines.
Three-Dose Hepatitis B Vaccine Regimen Can Protect Those With HIV
Previously hepatitis B vaccines have offered lower levels of protection for people living with HIV. New research indicates that a 3-dose series could offer much better protection.
49 New Therapies Approved by FDA Last Year
New approvals include gene therapies, first-in-class drugs, treatments for rare diseases, and cancer, as well as biosimilars.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
